Q1 2026 · 13F-HR
Alphabet Inc. (GOOG, GOOGL)holdings as filed
Filed 2026-05-08 · accession 0001652044-26-000051
$4.02B
Reported value
26
Positions
2026-03-31
Period end
The Brief · Alphabet Inc. (GOOG, GOOGL) · Q1 2026
AI · grounded in 13F
Alphabet Inc. established a new position in CME valued at $1.03B. The fund also opened new stakes in PAYP for $66.7M and LIFE for $42.1M. On the sell side, the fund closed its position in DXCM, reducing exposure by $68.8M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 12572Q105 | CME | CME GROUP INC | $1.03B | 25.6% | 3,484,020 | Common | SHARED |
| 72703X106 | PL | PLANET LABS PBC | $985.2M | 24.5% | 35,248,893 | Common | SHARED |
| 00217D100 | ASTS | AST SPACEMOBILE INC | $741.1M | 18.5% | 8,943,486 | Common | SHARED |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $320.2M | 7.97% | 3,292,525 | Common | SHARED |
| 042068205 | ARM | ARM HOLDINGS PLC | $296.6M | 7.39% | 1,960,784 | Common | SHARED |
| 358054104 | FRSH | FRESHWORKS INC | $130.1M | 3.24% | 16,206,643 | Common | SHARED |
| 90364P105 | PATH | UIPATH INC | $78.1M | 1.94% | 7,034,337 | Common | SHARED |
| 88023B103 | TEM | TEMPUS AI INC | $70.1M | 1.75% | 1,551,102 | Common | SHARED |
| 70450C101 | PAYP | PAYPAY CORP | $66.7M | 1.66% | 3,125,000 | Common | SHARED |
| 37637K108 | GTLB | GITLAB INC | $59.0M | 1.47% | 2,724,712 | Common | SHARED |
| 74168J101 | PRME | PRIME MEDICINE INC | $57.6M | 1.44% | 16,562,498 | Common | SHARED |
| 29765A101 | LIFE | ETHOS TECHNOLOGIES INC | $42.1M | 1.05% | 3,770,156 | Common | SHARED |
| 578784100 | MAZE | MAZE THERAPEUTICS INC | $41.4M | 1.03% | 1,388,583 | Common | SHARED |
| 107924102 | BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | $25.3M | 0.63% | 2,823,126 | Common | SHARED |
| 75943R102 | RLAY | RELAY THERAPEUTICS INC | $15.6M | 0.39% | 1,564,173 | Common | SHARED |
| 61225M102 | GLUE | MONTE ROSA THERAPEUTICS INC | $11.3M | 0.28% | 684,275 | Common | SHARED |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $9.7M | 0.24% | 241,264 | Common | SHARED |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $8.1M | 0.20% | 2,812,500 | Common | SHARED |
| 07373V105 | BEAM | BEAM THERAPEUTICS INC | $7.7M | 0.19% | 321,604 | Common | SHARED |
| 55083R203 | LYEL | LYELL IMMUNOPHARMA INC | $5.9M | 0.15% | 293,256 | Common | SHARED |
| 687793109 | OSCR | OSCAR HEALTH INC | $5.5M | 0.14% | 481,988 | Common | SHARED |
| 316841105 | FIG | FIGMA INC | $4.6M | 0.11% | 215,582 | Common | SHARED |
| 84833T103 | SPRO | SPERO THERAPEUTICS INC | $2.1M | 0.05% | 889,979 | Common | SHARED |
| 44916K106 | HYPR | HYPERFINE INC | $970,618 | 0.02% | 898,720 | Common | SHARED |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $963,602 | 0.02% | 698,262 | Common | SHARED |
| 87990A106 | TNYA | TENAYA THERAPEUTICS INC | $631,836 | 0.02% | 915,705 | Common | SHARED |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.